ACUTE LYMPHOCYTIC LEUKAEMIA

Clinical trials for ACUTE LYMPHOCYTIC LEUKAEMIA explained in plain language.

Never miss a new study

Get alerted when new ACUTE LYMPHOCYTIC LEUKAEMIA trials appear

Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

First patients receive experimental drug for aggressive leukemias

Disease control Terminated

This study was the first time a new drug called SAR443579 was tested in people. It aimed to find a safe dose and see if it could help control several aggressive blood cancers that had come back or stopped responding to other treatments. The trial included both adults and children…

Matched conditions: ACUTE LYMPHOCYTIC LEUKAEMIA

Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

ACUTE LYMPHOCYTIC LEUKAEMIA

Get alerted when new ACUTE LYMPHOCYTIC LEUKAEMIA trials appear

First patients receive experimental drug for aggressive leukemias